Skip to Main Content

Paper Details

Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes.
Nat Commun
18
2022
NSCLC, NSCLC patient-derived xenografts, Non-small cell lung cancer, PDX, PDX models, PDXs, RNA, adenocarcinoma, cancer, cancers, non-small cell lung cancer, normal tissue, patient, phosphotyrosine, squamous cell carcinoma
Author NameAffiliation
Shirley TamPrincess Margaret Cancer Centre, University Health Network
Nadeem MoghalPrincess Margaret Cancer Centre, University Health Network
Nhu-An PhamPrincess Margaret Cancer Centre, University Health Network
Jiefei TongHospital for Sick Children
Paul TaylorHospital for Sick Children
Ming LiPrincess Margaret Cancer Centre, University Health Network
Vibha RaghavanPrincess Margaret Cancer Centre, University Health Network
Shingo SakashitaPrincess Margaret Cancer Centre, University Health Network
Sameer AgnihotriJohn G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine
Thomas K WaddellToronto General Hospital, University Health Network
Thomas K WaddellUniversity of Toronto
Gelareh ZadehPrincess Margaret Cancer Centre, University Health Network
Gelareh ZadehUniversity of Toronto
Geoffrey LiuPrincess Margaret Cancer Centre, University Health Network
Geoffrey LiuUniversity of Toronto
Geoffrey LiuUniversity of Toronto
Frances A ShepherdPrincess Margaret Cancer Centre, University Health Network
Frances A ShepherdUniversity of Toronto
Michael F MoranHospital for Sick Children
Michael F MoranUniversity of Toronto
Michael F MoranPrincess Margaret Cancer Centre, University Health Network
Ming-Sound TsaoPrincess Margaret Cancer Centre, University Health Network
Ming-Sound TsaoUniversity of Toronto
Ming-Sound TsaoUniversity of Toronto
  • 1 - 24

Datasets

Release 1.2